4932417I16Rik Activators
4932417I16Rik Activators refer to a group of chemical entities that are capable of upregulating the expression of the 4932417I16Rik gene. These activators are commonly discovered through a process known as high-throughput screening (HTS), which enables the simultaneous testing of thousands of different chemical compounds for their effect on gene expression. The cornerstone of HTS in this context is the reporter gene assay, where a reporter gene-capable of producing a measurable product such as a fluorescent or luminescent marker-is operatively linked to the promoter of the 4932417I16Rik gene. Upon application of a chemical library to a cell line containing this construct, compounds that facilitate an increase in the activity of the 4932417I16Rik promoter cause an elevation in reporter gene expression. This increase manifests as an intensified signal, which is quantifiable and indicative of the compound's efficacy in activating the gene. Those compounds that lead to a discernible augmentation in the reporter's output are earmarked for further study, as they have demonstrated the initial capability to influence the expression of the 4932417I16Rik gene.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. This rise in calcium levels can activate calcium-dependent kinases and phosphatases that modulate the function of the 4932417I16Rik Protein. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to the phosphorylation of proteins in signaling pathways that include the 4932417I16Rik Protein, potentially enhancing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages with G protein-coupled receptors, which can initiate signaling cascades including MAPK and PI3K/AKT pathways that may involve and thereby enhance the activity of the 4932417I16Rik Protein. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific PKC inhibitor that can modulate PKC-mediated pathways. By inhibiting certain PKC isoforms, it may shift the signaling balance toward pathways that enhance the activity of 4932417I16Rik Protein. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit various protein kinases, potentially altering signaling pathways that indirectly increase the activity of 4932417I16Rik Protein by reducing competitive signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can modulate the PI3K/AKT pathway, leading to altered signaling dynamics that may enhance the function of the 4932417I16Rik Protein within this or related pathways. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB203580 is a p38 MAPK inhibitor that may shift signaling toward pathways where the 4932417I16Rik Protein is a component, potentially enhancing its activity by reducing p38 MAPK-mediated phosphorylation events. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor. By inhibiting PI3K, it can affect downstream signaling pathways and potentially enhance the activity of proteins, such as the 4932417I16Rik Protein, that are modulated by these pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can disrupt competitive signaling pathways, potentially leading to the upregulation of pathways that enhance the activity of the 4932417I16Rik Protein. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased intracellular calcium. This increase can activate calcium-dependent signaling mechanisms that enhance the activity of proteins like the 4932417I16Rik Protein. | ||||||